Found: 9
Select item for more details and to access through your institution.
Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
- Published in:
- Journal of Molecular Recognition, 1993, v. 6, n. 2, p. 81, doi. 10.1002/jmr.300060206
- By:
- Publication type:
- Article
Synthetic peptides as cancer vaccines.
- Published in:
- Biopolymers, 2002, v. 66, n. 3, p. 200, doi. 10.1002/bip.10258
- By:
- Publication type:
- Article
First prototype checkpoint inhibitor B-cell epitope vaccine (PD1-Vaxx) en route to human Phase 1 clinical trial in Australia and USA: exploiting future novel synergistic vaccine combinations.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cell attachment peptide of C-reactive protein: critical amino acids and minimum length.
- Published in:
- Journal of Cellular Biochemistry, 1994, v. 54, n. 3, p. 343, doi. 10.1002/jcb.240540310
- By:
- Publication type:
- Article
Design and use of peptide-based antibodies decreasing superoxide production by mitochondrial complex I and complex II.
- Published in:
- Biopolymers, 2011, v. 96, n. 2, p. 207, doi. 10.1002/bip.21457
- By:
- Publication type:
- Article
Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 4, p. 359, doi. 10.1038/sj.pcan.4500835
- By:
- Publication type:
- Article
Preclinical Studies of a Novel Human PD-1 B-Cell Peptide Cancer Vaccine PD1-Vaxx From BALB/c Mice to Beagle Dogs and to Non-Human Primates (Cynomolgus Monkeys).
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.826566
- By:
- Publication type:
- Article
Peptides of 23 residues or greater are required to stimulate a high affinity class II-restricted T cell response.
- Published in:
- European Journal of Immunology, 1993, v. 23, n. 5, p. 1011, doi. 10.1002/eji.1830230504
- By:
- Publication type:
- Article
Therapeutic Cancer Vaccines for the Management of Recurrent and Metastatic Head and Neck Cancer: A Review.
- Published in:
- JAMA Otolaryngology-Head & Neck Surgery, 2023, v. 149, n. 2, p. 168, doi. 10.1001/jamaoto.2022.4264
- By:
- Publication type:
- Article